The distance to a quasi 5000 photoelectric gene 12000 overweight medical degree

The distance of photoelectric announcement today, the company and the Hangzhou and one gene technology Co Ltd and its original shareholders in a day, Wang Pu Hangzhou venture investment partnership in the signing of the agreement, the company invested 49 million 500 thousand yuan to increase their investment and one gene, holds 15% of the shares.

Open since the beginning of the year to create "far distance photoelectric science and technology industry platform" strategy after long easy detection by investing mingzhan network, science and technology, and in the red phase, 3D printing, infrared imaging, photoelectric detection and other industrial areas have a good layout 4. Not long ago, photoelectric distance had announced on the NMR electronic business investment, the investment and the one entered the gene gene sequencing services, but also in two overweight medical industry.

Announcements, and a focus on gene gene technology research and industrialization, high-throughput gene sequencing technology based on advanced big data and cloud computing platform for hospitals, universities, research institutes, pharmaceutical companies and the public to provide gene sample treatment, gene sequencing and analysis report, large data storage and analysis, gene health management services, is widely used in disease pathogenesis research and drug development testing, medicine (non-invasive prenatal genetic testing, genetic cancer risk prediction, cancer screening and personalized medicine and health management guidance) gene (personal genome) multiple domain gene health industry. At present, and one gene has been in the country with hundreds of hospitals, research institutes and medical institutions, such as the establishment of a cooperative relationship.

Optical distance pointed out that by 2011, global gene sequencing technology market value has reached $3 billion, of which, gene sequencing technology market is divided into consumption class equipment and laboratory supplies, sequencing services and workflow products three market segments. By 2016, the global market value of sequencing services will reach $3 billion 500 million.

After this investment, Wang Jun, a photoelectric distance, and one day Pu venture holds 15% shares, 8.5% and 76.5% genes. Among them, Dr. Wang Junyi is founder and one gene, the gene sequencing has been engaged in related work in the study, and in the graduate school after seamless access to well-known gene sequencing, gene sequencing in the well-known institutions have many years of work experience from the grassroots to the executive team, after years of running, in the technology and market operation have accumulated a wealth of technical and management experience. And one gene under the leadership of the army, a year of entrepreneurship has nearly ten million yuan in sales revenue, close to breakeven point. At the same time, and one gene and its original shareholders commitment, from June 2015 to May 2018, the company will achieve operating income of 165 million yuan.

Open since the beginning of the year to create "far distance photoelectric science and technology industry platform" strategy after long easy detection by investing mingzhan network, science and technology, such as red phase, in the reasonable layout of 3D printing, infrared imaging, photoelectric detection and other industrial fields have 4.

According to previous reports, at the 2014 annual general meeting, chairman Pan Jiangen has said that the health care industry will be an important part of the company's future expansion. Not long ago, had announced on the photoelectric distance niumag electronic investment cost 16 million yuan, which holds 10% of the shares, formally enter the field of nuclear magnetic resonance, niumag electronic commitment over the next three years to achieve a net profit of 35 million yuan.

Distance optical said, the main field belong to gene sequencing detection technology service and company, in line with the development direction of the company established to extend the medical industry, the investment is the company's development strategy in the industry of science and technology platform of distance medical technology services in the direction of important layout.

Of particular note is that the distance photoelectric announcement also relates to company and one gene collaborative content, the announcement said the company will use its advantages in detection equipment and experience, and one gene to provide complete sets of testing equipment supporting services. If the company can get a synergistic effect, ability to cut the field of gene sequencing will significantly improve, the company not only can enter the gene sequencing detection equipment blue ocean market, will also greatly enhance the company's ability to integrate resources in gene sequencing industry.

For more information about LED, please click on China LED network or pay attention to WeChat public account (cnledw2013).